• ColoVantage
  • Company
    • History
    • Management Team
    • Board of Directors
    • Careers
  • Contact
  • Product
Clinical Genomics AUS
  • ColoVantage
  • Company
    • History
    • Management Team
    • Board of Directors
    • Careers
  • Contact
  • Product

Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society

Bridgewater, NJ – Wednesday, May 30, 2018

The ACS recommends that adults aged 45 years and older with an average risk of CRC undergo regular screening with either a high-sensitivity stool- based test or a structural (visual) examination. All positive results on non-colonoscopy screening tests should be followed up with timely colonoscopy.

Read the full guidelines here.

Billing
Careers
HIPAA/Privacy
Licenses
​Terms & Conditions
Clinical Genomics has offices and a NATA-accredited laboratory in North Ryde, NSW Australia.​

​
Copyright © 2019 Clinical Genomics Technologies Pty Ltd. All Rights Reserved.​
  • ColoVantage
  • Company
    • History
    • Management Team
    • Board of Directors
    • Careers
  • Contact
  • Product